Reshma Afsar
Licensed Practical Nurse Anaheim, CA Nurse Practitioner
NPI 1437682390 CMS profile 10866188
829 S Shanada Ct, Anaheim, CA 92807
General payments
$125
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Reshma Afsar of Anaheim, CA is reported in the CMS Open Payments database as having received $125 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 73rd percentile of Licensed Practical Nurse profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $125 | 1 |
Beside peers
- Reshma Afsar
- Licensed Practical Nurse median
- Middle half of Licensed Practical Nurse
- National median
In program year 2025, general payments to Reshma Afsar were reported at $0. Among 149 Licensed Practical Nurse profiles paid that year, the median was $39 and the middle half received between $23 and $109.
Show as a table
| Year | Reshma Afsar | Licensed Practical Nurse median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | — | — | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $0 | $29 | $19–$120 | $132 |
| 2022 | $0 | $35 | $19–$122 | $149 |
| 2023 | $125 | $51 | $18–$125 | $160 |
| 2024 | $0 | $53 | $23–$139 | $164 |
| 2025 | $0 | $39 | $23–$109 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 1 drugPart D claims
16
Drug cost
$44
Branded share of claims
0%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Latanoprost | Generic | 16 | $44 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Licensed Practical Nurse in California
Richard Twoy
Licensed Practical Nurse · San Jose, CA
Maryam Ahmadian
Licensed Practical Nurse · Beverly Hills, CA
Samrang Schimelpfenig
Licensed Practical Nurse · San Diego, CA
Farnoush Karimpour
Licensed Practical Nurse · Visalia, CA
Nastaran Minassians
Licensed Practical Nurse · Los Angeles, CA
Jayne Smith
Licensed Practical Nurse · Seal Beach, CA
Related records
Licensed Practical Nurse in California
Practitioners in the same specialty and state, ranked by reported value.
All Licensed Practical Nurse
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.